In the HALLMARK gene sets, pathways associated with cancer such as the p53 pathway, E2F targets, and kras signaling pathway were discovered to be notably enriched in the low-risk group, which corresponds to the observed aggressive traits of this group (Figure 7B). The gene discussed is KRAS; the disease is cancer.